These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2124009)

  • 41. [Phenotype profile of blood lymphocytes in bronchiolitis obliterans after lung transplantation].
    Fattal-German M; Cerrina J; Le Roy Ladurie F; Berrih-Aknin S
    Ann Pharm Fr; 1993; 51(3):125-34. PubMed ID: 8250490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor.
    Hertz MI; Henke CA; Nakhleh RE; Harmon KR; Marinelli WA; Fox JM; Kubo SH; Shumway SJ; Bolman RM; Bitterman PB
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10385-9. PubMed ID: 1438225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anatomoclinical diversity of bronchiolitis obliterans after lung transplantation. Anatomical study of 16 cases among 64 transplantations].
    Loire R; Brune J; Cordier JF; Mornex JF; Philit F; Roux N; Tabib A
    Arch Anat Cytol Pathol; 1993; 41(5-6):232-9. PubMed ID: 8135585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients.
    Studer SM; George MP; Zhu X; Song Y; Valentine VG; Stoner MW; Sethi J; Steele C; Duncan SR
    Am J Respir Crit Care Med; 2008 Oct; 178(7):765-73. PubMed ID: 18617642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphocyte subsets in distinct lung compartments show a different ability to produce interferon-gamma (IFN-gamma) during a pulmonary immune response.
    Klemm A; Tschernig T; Krug N; Pabst R
    Clin Exp Immunol; 1998 Aug; 113(2):252-7. PubMed ID: 9717975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bronchiolitis obliterans syndrome is associated with absence of suppression of peripheral blood Th1 proinflammatory cytokines.
    Hodge G; Hodge S; Chambers D; Reynolds PN; Holmes M
    Transplantation; 2009 Jul; 88(2):211-8. PubMed ID: 19623016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obliterative bronchiolitis after lung and heart-lung transplantation.
    Reichenspurner H; Girgis RE; Robbins RC; Conte JV; Nair RV; Valentine V; Berry GJ; Morris RE; Theodore J; Reitz BA
    Ann Thorac Surg; 1995 Dec; 60(6):1845-53. PubMed ID: 8787504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunophenotypic analysis of foal bronchoalveolar lavage lymphocytes.
    Balson GA; Smith GD; Yager JA
    Vet Microbiol; 1997 Jun; 56(3-4):237-46. PubMed ID: 9226838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients.
    Reynaud-Gaubert M; Thomas P; Gregoire R; Badier M; Cau P; Sampol J; Giudicelli R; Fuentes P
    Eur J Cardiothorac Surg; 2002 Jan; 21(1):60-6. PubMed ID: 11788258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.
    Fischbein MP; Yun J; Laks H; Irie Y; Fishbein MC; Espejo M; Bonavida B; Ardehali A
    Transplantation; 2001 Apr; 71(8):1146-53. PubMed ID: 11374417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats.
    Tu ZL; Zhou ZY; Xu HC; Cao JL; Ye P; Wang LM; Lv W; Hu J
    J Cardiothorac Surg; 2017 May; 12(1):43. PubMed ID: 28545478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The natural history of obliterative bronchiolitis and occlusive vascular disease of patients following heart-lung transplantation.
    Scott JP; Higenbottam TW; Clelland C; Hutter JA; Stewart S; Otulana BA; Wallwork J
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2592-3. PubMed ID: 2539680
    [No Abstract]   [Full Text] [Related]  

  • 54. The significance of bronchus-associated lymphoid tissue in human lung transplantation: is there an association with acute and chronic rejection?
    Hasegawa T; Iacono A; Yousem SA
    Transplantation; 1999 Feb; 67(3):381-5. PubMed ID: 10030282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunologically mediated disease of the airways after pulmonary transplantation.
    Griffith BP; Paradis IL; Zeevi A; Rabinowich H; Yousem SA; Duquesnoy RJ; Dauber JH; Hardesty RL
    Ann Surg; 1988 Sep; 208(3):371-8. PubMed ID: 3048217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
    Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans.
    Mimura T; Walker N; Aoki Y; Manning CM; Murdock BJ; Myers JL; Lagstein A; Osterholzer JJ; Lama VN
    Am J Pathol; 2015 Jun; 185(6):1564-74. PubMed ID: 25848843
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation.
    Engelmann I; Welte T; Fühner T; Simon AR; Mattner F; Hoy L; Schulz TF; Gottlieb J
    J Clin Virol; 2009 May; 45(1):47-53. PubMed ID: 19303808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Subsets of lymphocytes in bronchoalveolar-lavage fluid from patients with idiopathic bronchiolitis obliterans organizing pneumonia].
    Kusumoto H; Kunisawa A; Kuriyama Y; Yonemaru M; Nakano M; Ichinose Y; Ebihara Y; Toyama K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 May; 34(5):529-35. PubMed ID: 8753110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aggressive coronary artery vasculopathy after combined heart-lung transplantation.
    Hayes D; Baker PB; Astor TL; Preston TJ; Kirkby S; Galantowicz M; Hoffman TM
    Congenit Heart Dis; 2013; 8(3):E88-91. PubMed ID: 22676698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.